Page last updated: 2024-10-30

kynurenic acid and Facial Pain

kynurenic acid has been researched along with Facial Pain in 4 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research Excerpts

ExcerptRelevanceReference
"Kynurenic acid (KYNA) has well-established protective properties against glutamatergic neurotransmission, which plays an essential role in the activation and sensitization process during some primary headache disorders."1.46A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study. ( Bajtai, A; Bohár, Z; Fejes-Szabó, A; Fülöp, F; Laborc, K; László, AM; Mándity, I; Nagy-Grócz, G; Párdutz, Á; Szatmári, I; Szentirmai, M; Vécsei, L; Veres, G; Zádori, D, 2017)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cseh, EK1
Veres, G2
Körtési, T1
Polyák, H1
Nánási, N1
Tajti, J1
Párdutz, Á2
Klivényi, P1
Vécsei, L2
Zádori, D2
Fejes-Szabó, A1
Nagy-Grócz, G1
László, AM1
Bajtai, A1
Mándity, I1
Szentirmai, M1
Bohár, Z1
Laborc, K1
Szatmári, I1
Fülöp, F1
Yang, GY2
Woo, YW1
Park, MK2
Bae, YC2
Ahn, DK2
Bonfa, E1
Lee, JH1
Won, KA1
Kim, MJ1
Park, YY1

Other Studies

4 other studies available for kynurenic acid and Facial Pain

ArticleYear
Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain.
    The journal of headache and pain, 2020, Apr-21, Volume: 21, Issue:1

    Topics: Animals; Facial Pain; Freund's Adjuvant; gamma-Aminobutyric Acid; Glutamic Acid; Kynurenic Acid; Mal

2020
A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study.
    Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:1

    Topics: Analgesics; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Facial Pain; Form

2017
Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats.
    Journal of orofacial pain, 2010,Spring, Volume: 24, Issue:2

    Topics: Animals; Behavior, Animal; Cisterna Magna; Disease Models, Animal; Excitatory Amino Acid Antagonists

2010
Peripheral administration of NR2 antagonists attenuates orofacial formalin-induced nociceptive behavior in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4

    Topics: Animals; Behavior, Animal; Excitatory Amino Acid Antagonists; Facial Pain; Injections; Kynurenic Aci

2011